We first confirmed BAFF‐R expression on B cells from CLL patient and then successfully generated CLL patients derived CAR T cells that were functionally tested against both BAFF‐R‐positive cell lines and autologous primary tumor cells. This evidence concerns the gene TNFRSF13C and neoplasm.